{
    "title": "Does GSK have what it takes to become world-class again? asks ALEX BRUMMER as pharma giant gets set to hive off healthcare arm Haleon",
    "url": "https://www.dailymail.co.uk/money/comment/article-11018417/ALEX-BRUMMER-GSK-world-class-again.html",
    "date": "2022-07-15",
    "keywords": [
        "investment",
        "gsk",
        "haleon",
        "fund",
        "walmsley",
        "vaccine",
        "debt",
        "share",
        "cent",
        "case",
        "growth",
        "confidence",
        "healthcare",
        "emma",
        "pharma",
        "worldclass",
        "spite",
        "setback",
        "hiv",
        "covid",
        "risk",
        "target",
        "spinoff",
        "campus",
        "boss",
        "money",
        "diy",
        "platform",
        "research",
        "month",
        "purchase",
        "time",
        "market",
        "product",
        "account",
        "fee",
        "challenge",
        "street",
        "banking",
        "point",
        "top",
        "quarter",
        "italy",
        "eurozone",
        "sri",
        "lanka",
        "window",
        "world",
        "split",
        "ipo",
        "monday",
        "arm",
        "glaxosmithkline",
        "event",
        "end",
        "reorganisation",
        "executive",
        "innovator",
        "patientsthe",
        "task",
        "aggression",
        "investor",
        "elliott",
        "failure",
        "idea",
        "clearer",
        "run",
        "postsplit",
        "discount",
        "sector",
        "valuation",
        "takeover",
        "home",
        "sensodyne",
        "centrum",
        "firm",
        "interest",
        "decade",
        "plan",
        "way",
        "life",
        "science",
        "brummer",
        "splitout",
        "consumer",
        "article",
        "shringrix",
        "star",
        "performer",
        "prize",
        "work",
        "respiratory",
        "rsv",
        "autumn",
        "release",
        "heft",
        "process",
        "development",
        "stevenage",
        "biopharma"
    ],
    "category": [
        "money",
        "comment"
    ]
}